Quality of life in treated patients with acromegaly




Kauppinen-Makelin R, Sane T, Sintonen H, Markkanen H, Valimaki MJ, Loyttyniemi E, Niskanen L, Reunanen A, Stenman UH

PublisherENDOCRINE SOC

2006

Journal of Clinical Endocrinology and Metabolism

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

J CLIN ENDOCR METAB

91

10

3891

3896

6

0021-972X

DOIhttps://doi.org/10.1210/jc.2006-0676



Conclusions: HRQoL is reduced in treated patients with acromegaly. The best HRQoL may be achieved by normalization of IGF-I and by targeting the GHOGTT nadir to levels between 0.3 and 1.0 mu g/liter. Radiotherapy is associated with adverse HRQoL.



Last updated on 2024-26-11 at 15:09